Form 8-K - Current report:
SEC Accession No. 0001104659-25-038041
Filing Date
2025-04-23
Accepted
2025-04-23 16:31:02
Documents
20
Period of Report
2025-04-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512708d1_8k.htm   iXBRL 8-K 40979
2 EXHIBIT 10.1 tm2512708d1_ex10-1.htm EX-10.1 60208
3 EXHIBIT 10.2 tm2512708d1_ex10-2.htm EX-10.2 25688
4 EXHIBIT 10.3 tm2512708d1_ex10-3.htm EX-10.3 25633
5 EXHIBIT 10.4 tm2512708d1_ex10-4.htm EX-10.4 34016
6 EXHIBIT 10.5 tm2512708d1_ex10-5.htm EX-10.5 33872
7 EXHIBIT 10.6 tm2512708d1_ex10-6.htm EX-10.6 33414
8 EXHIBIT 10.7 tm2512708d1_ex10-7.htm EX-10.7 33229
  Complete submission text file 0001104659-25-038041.txt   518071

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA knsa-20250417.xsd EX-101.SCH 3011
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20250417_lab.xml EX-101.LAB 34239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20250417_pre.xml EX-101.PRE 22356
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2512708d1_8k_htm.xml XML 3595
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 25862025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)